YonasEndaleGedaMD
Psychiatry • Phoenix, AZNeuropsychiatry
Professor, Alzheimer's and Memory Disorders Program, Department of Neurology. Barrow Neurological Institute, Phoenix, Arizona.
Dr. Geda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
240 W Thomas Road. Suite 301
Phoenix, AZ 85013Phone+1 602-406-6262Fax+1 602-230-6422
Summary
- Dr Yonas Geda is a Professor at Barrow Neurological Institute, Phoenix, Arizona, USA. Professor Geda is a Behavioral Neurologist, in the Division of Alzheimer's Disease and Memory Disorders Program, Department of Neurology, Barrow Neurological Institute Phoenix, Arizona USA. Dr Geda completed his trainings in Psychiatry, Behavioral Neurology and Biomedical science, Clinical Research at Mayo Clinic in Rochester, Minnesota (1995-2000). Prior to that he earned his MD degree from Addis Ababa (Haile Selassie) University then worked as General medical practitioner for 2 years in Addis Ababa, Ethiopia. Following his trainings in residency and fellowship, in 2000, Dr Geda became a full time faculty at Mayo Clinic. In 2014, Dr Geda became the first physician at Mayo Clinic to have an academic rank of full Professor in both fields of Neurology and Psychiatry. After 20 years of serving as full time faculty at Mayo clinic then in 2020, Dr Geda made a vertical career move as Professor and Program Director of the Behavioral Neurology and Neuropsychiatry Fellowship Program in the Department of Neurology at Barrow Neurological Institute, Phoenix, Arizona, USA. Since July of 2020, Dr Geda has become Research Professor, Center for Biosensors and Bioelectronics, Arizona State University.
Dr Geda has authored over 175 peer reviewed scientific publications including in prestigious journals such as JAMA Psychiatry, JAMA Neurology, American Journal of Psychiatry, Neurology etc. Dr Geda is the lead author of the international panel that developed the neurobiological model to investigate neuropsychiatric symptoms in Alzheimer's Disease. (Geda et al. Alzheimer's & Dementia. 2013). Professor Yonas Geda is a globally recognized influential expert in the field of neuropsychiatry, brain aging, Alzheimer's disease and related disorders as evidenced by 10220 citations of his work and an h-index of 53 (Geda Y.E. SCOPUS report. February 25, 2021).
Education & Training
Mayo Graduate SchoolMSc, Biomedical Science, Clinical Research, GPA = 3.8, 2004 - 2006
Mayo Clinic College of Medicine and ScienceFellowship, Behavioral neurology, 2000 - 2001- Mayo Clinic College of Medicine and Science (Rochester)Residency, Psychiatry, 1996 - 1999
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Psychiatry, 1995 - 1995
Addis Ababa University Faculty of MedicineClass of 1991
Certifications & Licensure
AZ State Medical License 2007 - 2026
FL State Medical License 2000 - 2026
MN State Medical License 1997 - 2024- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Consultation-Liaison Psychiatry
- United Council for Neurologic SubspecialitiesBehavioral Neurology and Neuropsychiatry
Awards, Honors, & Recognition
- Recipient of Medal of the City of La Ciotat City of La Ciotat, 2016
- International Psychogeriatric Research Award 2003
- Recipient of Medal of the City of Marseille “Ville De Marseille" Mayor of the City of Marseille, 2003
- Join now to see all
Clinical Trials
- Committed Actions for Successful Aging Start of enrollment: 2016 May 01
- Time Restricted Eating in Alzheimer's Disease (TREAD) Start of enrollment: 2023 Mar 15
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 965 citationsMild cognitive impairment: ten years later.Ronald C. Petersen, Rosebud O. Roberts, David S. Knopman, Bradley F. Boeve, Yonas E. Geda
Archives of Neurology. 2009-12-01 - 301 citationsHigher risk of progression to dementia in mild cognitive impairment cases who revert to normalRosebud O. Roberts, David S. Knopman, Michelle M. Mielke, Ruth H. Cha, V. Shane Pankratz
Neurology. 2014-01-28 - 242 citationsThe association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.Paul B. Rosenberg, Michelle M. Mielke, Brian S. Appleby, Esther S. Oh, Yonas E. Geda
The American Journal of Geriatric Psychiatry. 2012-04-27
Journal Articles
- Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without DementiaMary M Machulda, Ronald C Petersen, David S Knopman, Yonas E Geda, Val J Lowe, Journal of the American Geriatrics Society
- The Association of Multimorbidity with Preclinical AD Stages and SNAP in Cognitively Unimpaired PersonsRonald C Petersen, Yonas E Geda, David S Knopman, Mary M Machulda, Val J Lowe, The Journals of Gerontology
- Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based SettingMary M Machulda, David S Knopman, Yonas E Geda, Val J Lowe, Ronald C Petersen, JAMA
- Join now to see all
Press Mentions
Anxiety May Amplify Risk of Cognitive ImpairmentDecember 15th, 2021- PET Links Anxiety and Risk of Cognitive DeclineDecember 13th, 2021
- 5 Reasons Why You Should Learn to CrochetOctober 6th, 2019
- Join now to see all
Grant Support
- Psychiatric Characterization/Mild Cognitive ImpairmentNational Institute Of Mental Health2004–2008
Committees
- Chairman, Awards Committe of the Neuropsychiatry Professional Interest Area of Alzheimer's Association 2012 - 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
